Found: 400
Select item for more details and to access through your institution.
Final analyses of the prospective controlled trial on the efficacy of uracil and tegafur/leucovorin as an adjuvant treatment for stage II colon cancer with risk factors for recurrence using propensity score-based methods (JFMC46-1201).
- Published in:
- International Journal of Clinical Oncology, 2024, v. 29, n. 9, p. 1284, doi. 10.1007/s10147-024-02565-5
- By:
- Publication type:
- Article
Long-term outcomes of neoadjuvant trastuzumab emtansine + pertuzumab (T-DM1 + P) and docetaxel + carboplatin + trastuzumab + pertuzumab (TCbHP) for HER2-positive primary breast cancer: results of the randomized phase 2 JBCRG20 study (Neo-peaks)
- Published in:
- Breast Cancer Research & Treatment, 2024, v. 207, n. 1, p. 33, doi. 10.1007/s10549-024-07333-7
- By:
- Publication type:
- Article
Exploratory prospective, randomized phase II study of neoadjuvant transcatheter arterial chemoembolization plus surgery versus surgery alone for large hepatocellular carcinoma (CSGO‐HBP‐005): Clinical Study Group of Osaka University, Hepato‐Biliary‐Pancreatic Group
- Published in:
- Hepatology Research, 2024, v. 54, n. 7, p. 667, doi. 10.1111/hepr.14013
- By:
- Publication type:
- Article
Comparison of cisplatin-based versus standard preoperative chemotherapy in patients with operable triple-negative breast cancer: propensity score matching and inverse probability of treatment weighting analysis.
- Published in:
- Breast Cancer Research & Treatment, 2024, v. 204, n. 2, p. 261, doi. 10.1007/s10549-023-07163-z
- By:
- Publication type:
- Article
BOIN-ETC: A Bayesian optimal interval design considering efficacy and toxicity to identify the optimal dose combinations.
- Published in:
- Statistical Methods in Medical Research, 2024, v. 33, n. 4, p. 716, doi. 10.1177/09622802241236936
- By:
- Publication type:
- Article
Hyposecretion of cervical MUC5B is related to preterm birth in pregnant women after cervical excisional surgery.
- Published in:
- American Journal of Reproductive Immunology, 2024, v. 91, n. 3, p. 1, doi. 10.1111/aji.13832
- By:
- Publication type:
- Article
Exploratory Biomarker Analysis Using Plasma Angiogenesis-Related Factors and Cell-Free DNA in the TRUSTY Study: A Randomized, Phase II/III Study of Trifluridine/Tipiracil Plus Bevacizumab as Second-Line Treatment for Metastatic Colorectal Cancer.
- Published in:
- Targeted Oncology, 2024, v. 19, n. 1, p. 59, doi. 10.1007/s11523-023-01027-8
- By:
- Publication type:
- Article
Bayesian predictive model averaging approach to joint longitudinal‐survival modeling: Application to an immuno‐oncology clinical trial.
- Published in:
- Statistics in Medicine, 2023, v. 42, n. 27, p. 4990, doi. 10.1002/sim.9897
- By:
- Publication type:
- Article
Frequentist analysis of basket trials with one‐sample Mantel‐Haenszel procedures.
- Published in:
- Statistics in Medicine, 2023, v. 42, n. 26, p. 4824, doi. 10.1002/sim.9890
- By:
- Publication type:
- Article
Hyperfructosemia in sleep disordered breathing: metabolome analysis of Nagahama study.
- Published in:
- Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-40002-1
- By:
- Publication type:
- Article
Prognostic factors in patients with high-risk stage II colon cancer after curative resection: a post hoc analysis of the JFMC46-1201 trial.
- Published in:
- International Journal of Colorectal Disease, 2023, v. 38, n. 1, p. 1, doi. 10.1007/s00384-023-04559-7
- By:
- Publication type:
- Article
Structure of spirituality among high-school students differs depending on relationship with someone or something Greater (RSG).
- Published in:
- Current Psychology, 2023, v. 42, n. 30, p. 26709, doi. 10.1007/s12144-022-03694-8
- By:
- Publication type:
- Article
Correction to: Structure of spirituality among high-school students differs depending on relationship with someone or something Greater (RSG).
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
TITE‐gBOIN‐ET: Time‐to‐event generalized Bayesian optimal interval design to accelerate dose‐finding accounting for ordinal graded efficacy and toxicity outcomes.
- Published in:
- Biometrical Journal, 2023, v. 65, n. 7, p. 1, doi. 10.1002/bimj.202200265
- By:
- Publication type:
- Article
Associations between Sleep-Disordered Breathing and Serum Uric Acid and Their Sex Differences: The Nagahama Study.
- Published in:
- Nutrients, 2023, v. 15, n. 19, p. 4237, doi. 10.3390/nu15194237
- By:
- Publication type:
- Article
Performance of dedicated breast PET in breast cancer screening: comparison with digital mammography plus digital breast tomosynthesis and ultrasound.
- Published in:
- Annals of Nuclear Medicine, 2023, v. 37, n. 9, p. 479, doi. 10.1007/s12149-023-01846-9
- By:
- Publication type:
- Article
Fulvestrant with or without anti‐HER2 therapy in patients in a postmenopausal hormonal state and with ER‐positive HER2‐positive advanced or metastatic breast cancer: A subgroup analysis of data from the Safari study (JBCRG‐C06).
- Published in:
- Cancer Medicine, 2023, v. 12, n. 17, p. 17718, doi. 10.1002/cam4.6390
- By:
- Publication type:
- Article
Higher hemoglobin levels using darbepoetin alfa and kidney outcomes in advanced chronic kidney disease without diabetes: a prespecified secondary analysis of the PREDICT trial.
- Published in:
- Clinical & Experimental Nephrology, 2023, v. 27, n. 9, p. 757, doi. 10.1007/s10157-023-02362-w
- By:
- Publication type:
- Article
Hyperfructosemia in sleep disordered breathing: metabolome analysis of Nagahama study.
- Published in:
- Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-40002-1
- By:
- Publication type:
- Article
CD47 polymorphism for predicting nivolumab benefit in patients with advanced non-small-cell lung cancer.
- Published in:
- Oncology Letters, 2023, v. 26, n. 2, p. 1, doi. 10.3892/ol.2023.13950
- By:
- Publication type:
- Article
Biomarker‐based Bayesian randomized clinical trial design for identifying a target population.
- Published in:
- Statistics in Medicine, 2023, v. 42, n. 16, p. 2797, doi. 10.1002/sim.9749
- By:
- Publication type:
- Article
Epigenetic mechanisms to propagate histone acetylation by p300/CBP.
- Published in:
- Nature Communications, 2023, v. 14, n. 1, p. 1, doi. 10.1038/s41467-023-39735-4
- By:
- Publication type:
- Article
Nighttime hypoglycemia in Japanese children with type 1 diabetes mellitus treated with multiple daily injection insulin therapy.
- Published in:
- Endocrine Journal, 2023, v. 70, n. 7, p. 677, doi. 10.1507/endocrj.ej22-0379
- By:
- Publication type:
- Article
Sleep disordered breathing and haemoglobin A1c levels within or over normal range and ageing or sex differences: the Nagahama study.
- Published in:
- Journal of Sleep Research, 2023, v. 32, n. 3, p. 1, doi. 10.1111/jsr.13795
- By:
- Publication type:
- Article
Trifluridine/tipiracil+bevacizumab (BEV) vs. fluoropyrimidine-irinotecan+BEV as second-line therapy for metastatic colorectal cancer: a randomised noninferiority trial.
- Published in:
- British Journal of Cancer, 2023, v. 128, n. 10, p. 1897, doi. 10.1038/s41416-023-02212-2
- By:
- Publication type:
- Article
Comprehensive data of 4502 patients newly diagnosed with colorectal liver metastasis between 2015 and 2017, and prognostic data of 2427 patients newly diagnosed with colorectal liver metastasis in 2013 and 2014: Third report of a nationwide survey in Japan
- Published in:
- Journal of Hepato -- Biliary -- Pancreatic Sciences, 2023, v. 30, n. 5, p. 570, doi. 10.1002/jhbp.1252
- By:
- Publication type:
- Article
Validation study of the JSHBPS nomogram for patients with colorectal liver metastases who underwent hepatic resection in the recent era ‐ a nationwide survey in Japan.
- Published in:
- Journal of Hepato -- Biliary -- Pancreatic Sciences, 2023, v. 30, n. 5, p. 591, doi. 10.1002/jhbp.1256
- By:
- Publication type:
- Article
Impact of prior chemotherapy with two different fluoropyrimidines on the efficacy of capecitabine plus irinotecan or FOLFIRI with or without bevacizumab in metastatic colorectal cancer: a post hoc analysis of the AXEPT study.
- Published in:
- Cancer Communications, 2023, v. 43, n. 4, p. 519, doi. 10.1002/cac2.12406
- By:
- Publication type:
- Article
Retrospective study on the effectiveness of medroxyprogesterone acetate in the treatment of ER-positive/HER2-negative post-menopausal advanced breast cancer: an additional analysis of the JBCRG-C06 Safari study.
- Published in:
- Japanese Journal of Clinical Oncology, 2023, v. 53, n. 3, p. 203, doi. 10.1093/jjco/hyac184
- By:
- Publication type:
- Article
Non-monotonic behavior of the Binder parameter in discrete spin systems.
- Published in:
- Progress of Theoretical & Experimental Physics: PTEP, 2023, v. 2023, n. 3, p. 1, doi. 10.1093/ptep/ptad022
- By:
- Publication type:
- Article
Real-world effect of bevacizumab and eribulin on metastatic breast cancer using a propensity score matching analysis.
- Published in:
- Molecular & Clinical Oncology, 2023, v. 18, n. 2, p. N.PAG, doi. 10.3892/mco.2023.2608
- By:
- Publication type:
- Article
Factors affecting prognosis in patients treated with bevacizumab plus paclitaxel as first-line chemotherapy for HER2-negative metastatic breast cancer: an international pooled analysis of individual patient data from four prospective observational studies
- Published in:
- Breast Cancer (13406868), 2023, v. 30, n. 1, p. 88, doi. 10.1007/s12282-022-01399-1
- By:
- Publication type:
- Article
Overall survival analysis of patients enrolled in a randomized phase III trial comparing gefitinib and erlotinib for previously treated advanced lung adenocarcinoma (WJOG5108LFS).
- Published in:
- International Journal of Clinical Oncology, 2023, v. 28, n. 1, p. 79, doi. 10.1007/s10147-022-02266-x
- By:
- Publication type:
- Article
Postoperative tegafur–uracil for stage I lung adenocarcinoma: first real-world data with an exploratory subgroup analysis.
- Published in:
- Surgery Today, 2023, v. 53, n. 1, p. 135, doi. 10.1007/s00595-022-02546-z
- By:
- Publication type:
- Article
Phase Ib/II study of nivolumab combined with palliative radiation therapy for bone metastasis in patients with HER2-negative metastatic breast cancer.
- Published in:
- Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-022-27048-3
- By:
- Publication type:
- Article
Dose-finding trial of azacitidine as post-transplant maintenance for high-risk MDS: a KSGCT prospective study.
- Published in:
- Annals of Hematology, 2022, v. 101, n. 12, p. 2719, doi. 10.1007/s00277-022-04981-x
- By:
- Publication type:
- Article
Efficacy and Safety of Brazilian Green Propolis in Biochemically Recurrent Prostate Cancer after Radical Prostatectomy: A Single-Arm Phase II Study.
- Published in:
- International Journal of Translational Medicine, 2022, v. 2, n. 4, p. 618, doi. 10.3390/ijtm2040047
- By:
- Publication type:
- Article
A phase II study of carboplatin and etoposide plus durvalumab for previously untreated extensive-stage small-cell lung cancer (ES-SCLC) patients with a poor performance status (PS): NEJ045A study protocol.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Immune‐related adverse events in urothelial cancer patients: Adjustment for immortal time bias.
- Published in:
- Cancer Science, 2022, v. 113, n. 11, p. 3912, doi. 10.1111/cas.15539
- By:
- Publication type:
- Article
Correction to: Clinical usefulness of eribulin as first- or second-line chemotherapy for recurrent HER2-negative breast cancer: a randomized phase II study (JBCRG-19).
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice
Co-expression effect of LLGL2 and SLC7A5 to predict prognosis in ERα-positive breast cancer.
- Published in:
- Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-022-20225-4
- By:
- Publication type:
- Article
gBOIN‐ET: The generalized Bayesian optimal interval design for optimal dose‐finding accounting for ordinal graded efficacy and toxicity in early clinical trials.
- Published in:
- Biometrical Journal, 2022, v. 64, n. 7, p. 1178, doi. 10.1002/bimj.202100263
- By:
- Publication type:
- Article
Pertuzumab retreatment for HER2‐positive advanced breast cancer: A randomized, open‐label phase III study (PRECIOUS).
- Published in:
- Cancer Science, 2022, v. 113, n. 9, p. 3169, doi. 10.1111/cas.15474
- By:
- Publication type:
- Article
Treatment of rheumatoid arthritis and its outcomes in an aging society: a single-center cohort study in Japan from 2011 to 2020.
- Published in:
- Arthritis Research & Therapy, 2022, v. 24, n. 1, p. 1, doi. 10.1186/s13075-022-02883-x
- By:
- Publication type:
- Article
Impact of early tumor shrinkage on quality of life in patients treated with first-line cetuximab plus chemotherapy for unresectable metastatic colorectal cancer: results of Phase II QUACK trial.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Factors associated with overall survival after recurrence in patients with ER-positive/HER2-negative postmenopausal breast cancer: an ad hoc analysis of the JBCRG-C06 Safari study.
- Published in:
- Japanese Journal of Clinical Oncology, 2022, v. 52, n. 6, p. 545, doi. 10.1093/jjco/hyac022
- By:
- Publication type:
- Article
A randomized controlled trial of surgery and postoperative modified FOLFOX6 versus surgery and perioperative modified FOLFOX6 plus cetuximab in patients with KRAS wild-type resectable colorectal liver metastases: EXPERT study.
- Published in:
- Langenbeck's Archives of Surgery, 2022, v. 407, n. 4, p. 1345, doi. 10.1007/s00423-022-02434-7
- By:
- Publication type:
- Article
No impact of donor sex on the recurrence of hepatocellular carcinoma after liver transplantation.
- Published in:
- Journal of Hepato -- Biliary -- Pancreatic Sciences, 2022, v. 29, n. 5, p. 570, doi. 10.1002/jhbp.1134
- By:
- Publication type:
- Article
Immune microenvironment, homologous recombination deficiency, and therapeutic response to neoadjuvant chemotherapy in triple-negative breast cancer: Japan Breast Cancer Research Group (JBCRG)22 TR.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Correction to: Osimertinib in poor performance status patients with T790M‑positive advanced non‑small‑cell lung cancer after progression of first- and second‑generation EGFR‑TKI treatments (NEJ032B).
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice